nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CALM1—trigeminal nerve—bone cancer	0.0103	0.14	CbGeAlD
Fluphenazine—HRH1—nose—bone cancer	0.00954	0.13	CbGeAlD
Fluphenazine—Faecaloma—Epirubicin—bone cancer	0.00921	0.0298	CcSEcCtD
Fluphenazine—Faecalith—Epirubicin—bone cancer	0.00921	0.0298	CcSEcCtD
Fluphenazine—Faecaloma—Doxorubicin—bone cancer	0.00852	0.0276	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—bone cancer	0.00852	0.0276	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—bone cancer	0.00788	0.0255	CcSEcCtD
Fluphenazine—CALM1—cranial nerve—bone cancer	0.00731	0.0999	CbGeAlD
Fluphenazine—Pigmentation disorder—Doxorubicin—bone cancer	0.00729	0.0236	CcSEcCtD
Fluphenazine—HTR2A—trigeminal nerve—bone cancer	0.00625	0.0854	CbGeAlD
Fluphenazine—Liver injury—Cisplatin—bone cancer	0.00609	0.0197	CcSEcCtD
Fluphenazine—Tenderness—Cisplatin—bone cancer	0.00587	0.019	CcSEcCtD
Fluphenazine—Appetite absent—Methotrexate—bone cancer	0.00565	0.0183	CcSEcCtD
Fluphenazine—Hepatocellular injury—Cisplatin—bone cancer	0.00512	0.0166	CcSEcCtD
Fluphenazine—Body temperature increased—Carboplatin—bone cancer	0.00493	0.0159	CcSEcCtD
Fluphenazine—HTR2A—cranial nerve—bone cancer	0.00445	0.0608	CbGeAlD
Fluphenazine—HTR2A—vertebral column—bone cancer	0.00437	0.0597	CbGeAlD
Fluphenazine—Polyuria—Cisplatin—bone cancer	0.00424	0.0137	CcSEcCtD
Fluphenazine—Nasal congestion—Cisplatin—bone cancer	0.00408	0.0132	CcSEcCtD
Fluphenazine—Renal failure acute—Cisplatin—bone cancer	0.00403	0.013	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.00386	0.0125	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Cisplatin—bone cancer	0.00384	0.0124	CcSEcCtD
Fluphenazine—HTR2A—hindlimb—bone cancer	0.00375	0.0513	CbGeAlD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.00357	0.0116	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—bone cancer	0.00355	0.0115	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—bone cancer	0.00329	0.0106	CcSEcCtD
Fluphenazine—HTR2A—appendage—bone cancer	0.00322	0.044	CbGeAlD
Fluphenazine—Blood disorder—Epirubicin—bone cancer	0.00315	0.0102	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—bone cancer	0.00313	0.0101	CcSEcCtD
Fluphenazine—Pancytopenia—Cisplatin—bone cancer	0.00305	0.00988	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—bone cancer	0.00299	0.00969	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—bone cancer	0.00291	0.00943	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—bone cancer	0.00289	0.00936	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—bone cancer	0.0028	0.00906	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—bone cancer	0.00277	0.00897	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—bone cancer	0.00263	0.00851	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—bone cancer	0.0026	0.00841	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—bone cancer	0.00259	0.00838	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—bone cancer	0.00255	0.00827	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—bone cancer	0.00254	0.00823	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—bone cancer	0.00252	0.00814	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—bone cancer	0.00243	0.00788	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—bone cancer	0.00241	0.00779	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—bone cancer	0.00236	0.00765	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—bone cancer	0.00232	0.00752	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—bone cancer	0.00232	0.00752	CcSEcCtD
Fluphenazine—Erythema—Cisplatin—bone cancer	0.00224	0.00725	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—bone cancer	0.00221	0.00715	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—bone cancer	0.00217	0.00704	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—bone cancer	0.00216	0.007	CcSEcCtD
Fluphenazine—Muscle spasms—Cisplatin—bone cancer	0.00215	0.00697	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—bone cancer	0.00212	0.00688	CcSEcCtD
Fluphenazine—Vision blurred—Cisplatin—bone cancer	0.00211	0.00683	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—bone cancer	0.00211	0.00682	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—bone cancer	0.00208	0.00674	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—bone cancer	0.00207	0.00669	CcSEcCtD
Fluphenazine—Mequitazine—CYP3A4—bone cancer	0.00206	0.174	CrCbGaD
Fluphenazine—Dermatitis exfoliative—Epirubicin—bone cancer	0.00202	0.00655	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—bone cancer	0.00201	0.00651	CcSEcCtD
Fluphenazine—Leukopenia—Cisplatin—bone cancer	0.002	0.00649	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—bone cancer	0.00197	0.00639	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—bone cancer	0.00197	0.00636	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—bone cancer	0.00195	0.00631	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—bone cancer	0.00191	0.00619	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00187	0.00606	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cisplatin—bone cancer	0.00183	0.00592	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00183	0.00591	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—bone cancer	0.00182	0.00588	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—bone cancer	0.0018	0.00584	CcSEcCtD
Fluphenazine—Tachycardia—Cisplatin—bone cancer	0.00178	0.00577	CcSEcCtD
Fluphenazine—Skin disorder—Cisplatin—bone cancer	0.00178	0.00575	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—bone cancer	0.00176	0.00571	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—bone cancer	0.00175	0.00565	CcSEcCtD
Fluphenazine—Hypotension—Cisplatin—bone cancer	0.00171	0.00553	CcSEcCtD
Fluphenazine—Nefazodone—CYP3A4—bone cancer	0.00169	0.142	CrCbGaD
Fluphenazine—Cardiac arrest—Doxorubicin—bone cancer	0.00168	0.00544	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—bone cancer	0.00167	0.00542	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—bone cancer	0.00165	0.00534	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—bone cancer	0.00165	0.00534	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—bone cancer	0.00164	0.0053	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—bone cancer	0.00163	0.00529	CcSEcCtD
Fluphenazine—Dyspnoea—Cisplatin—bone cancer	0.00163	0.00527	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—bone cancer	0.00161	0.00521	CcSEcCtD
Fluphenazine—Decreased appetite—Cisplatin—bone cancer	0.00159	0.00514	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—bone cancer	0.00158	0.00512	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—bone cancer	0.00157	0.00509	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—bone cancer	0.00157	0.00507	CcSEcCtD
Fluphenazine—Trazodone—CYP3A4—bone cancer	0.00156	0.132	CrCbGaD
Fluphenazine—Upper respiratory tract infection—Epirubicin—bone cancer	0.00153	0.00496	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—bone cancer	0.00153	0.00494	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—bone cancer	0.00153	0.00494	CcSEcCtD
Fluphenazine—CALM2—connective tissue—bone cancer	0.00152	0.0207	CbGeAlD
Fluphenazine—Eosinophilia—Doxorubicin—bone cancer	0.00151	0.00489	CcSEcCtD
Fluphenazine—CALM1—connective tissue—bone cancer	0.00151	0.0206	CbGeAlD
Fluphenazine—Photosensitivity reaction—Epirubicin—bone cancer	0.00151	0.00488	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—bone cancer	0.00148	0.00479	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—bone cancer	0.00147	0.00476	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—bone cancer	0.00147	0.00475	CcSEcCtD
Fluphenazine—Pipotiazine—CYP3A4—bone cancer	0.00147	0.124	CrCbGaD
Fluphenazine—Pancytopenia—Doxorubicin—bone cancer	0.00145	0.00469	CcSEcCtD
Fluphenazine—Body temperature increased—Cisplatin—bone cancer	0.00144	0.00468	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00142	0.00459	CcSEcCtD
Fluphenazine—Prochlorperazine—CYP3A4—bone cancer	0.0014	0.118	CrCbGaD
Fluphenazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00139	0.00451	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—bone cancer	0.00137	0.00444	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—bone cancer	0.00137	0.00443	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—bone cancer	0.00136	0.00441	CcSEcCtD
Fluphenazine—Hypersensitivity—Cisplatin—bone cancer	0.00135	0.00436	CcSEcCtD
Fluphenazine—CALM3—tendon—bone cancer	0.00133	0.0181	CbGeAlD
Fluphenazine—Oedema peripheral—Epirubicin—bone cancer	0.0013	0.00421	CcSEcCtD
Fluphenazine—CALM3—bone marrow—bone cancer	0.00128	0.0176	CbGeAlD
Fluphenazine—CALM3—spinal cord—bone cancer	0.00128	0.0175	CbGeAlD
Fluphenazine—Agranulocytosis—Doxorubicin—bone cancer	0.00127	0.00411	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—bone cancer	0.00123	0.00398	CcSEcCtD
Fluphenazine—HTR2C—spinal cord—bone cancer	0.00121	0.0166	CbGeAlD
Fluphenazine—Oedema peripheral—Doxorubicin—bone cancer	0.0012	0.0039	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—bone cancer	0.00116	0.00375	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—bone cancer	0.00115	0.00372	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—bone cancer	0.00111	0.00358	CcSEcCtD
Fluphenazine—HRH1—connective tissue—bone cancer	0.0011	0.015	CbGeAlD
Fluphenazine—Leukopenia—Methotrexate—bone cancer	0.0011	0.00356	CcSEcCtD
Fluphenazine—Nausea—Cisplatin—bone cancer	0.00109	0.00351	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—bone cancer	0.00108	0.00351	CcSEcCtD
Fluphenazine—ADRA2A—connective tissue—bone cancer	0.00108	0.0148	CbGeAlD
Fluphenazine—Erythema—Doxorubicin—bone cancer	0.00106	0.00344	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—bone cancer	0.00106	0.00342	CcSEcCtD
Fluphenazine—CALM2—tendon—bone cancer	0.00104	0.0142	CbGeAlD
Fluphenazine—CALM1—tendon—bone cancer	0.00104	0.0142	CbGeAlD
Fluphenazine—Leukopenia—Epirubicin—bone cancer	0.00103	0.00333	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—bone cancer	0.00102	0.00331	CcSEcCtD
Fluphenazine—HTR1A—spinal cord—bone cancer	0.00102	0.014	CbGeAlD
Fluphenazine—CALM2—bone marrow—bone cancer	0.00101	0.0138	CbGeAlD
Fluphenazine—CALM2—spinal cord—bone cancer	0.001	0.0137	CbGeAlD
Fluphenazine—CALM1—bone marrow—bone cancer	0.001	0.0137	CbGeAlD
Fluphenazine—Anaphylactic shock—Methotrexate—bone cancer	0.001	0.00325	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—bone cancer	0.001	0.00325	CcSEcCtD
Fluphenazine—Perphenazine—CYP3A4—bone cancer	0.001	0.0844	CrCbGaD
Fluphenazine—CALM1—spinal cord—bone cancer	0.001	0.0137	CbGeAlD
Fluphenazine—Hypertension—Epirubicin—bone cancer	0.000993	0.00321	CcSEcCtD
Fluphenazine—Quetiapine—CYP3A4—bone cancer	0.000982	0.0828	CrCbGaD
Fluphenazine—Agitation—Doxorubicin—bone cancer	0.000978	0.00316	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—bone cancer	0.000974	0.00315	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—bone cancer	0.000958	0.0031	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—bone cancer	0.000953	0.00308	CcSEcCtD
Fluphenazine—Anaphylactic shock—Epirubicin—bone cancer	0.000939	0.00304	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—bone cancer	0.000937	0.00303	CcSEcCtD
Fluphenazine—HTR2A—connective tissue—bone cancer	0.000919	0.0126	CbGeAlD
Fluphenazine—Hypertension—Doxorubicin—bone cancer	0.000919	0.00297	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—bone cancer	0.000916	0.00296	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—bone cancer	0.000912	0.00295	CcSEcCtD
Fluphenazine—Promazine—CYP3A4—bone cancer	0.000903	0.0761	CrCbGaD
Fluphenazine—Dyspnoea—Methotrexate—bone cancer	0.000894	0.00289	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—bone cancer	0.000892	0.00289	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—bone cancer	0.000886	0.00287	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—bone cancer	0.000877	0.00284	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—bone cancer	0.000872	0.00282	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—bone cancer	0.000868	0.00281	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—bone cancer	0.000848	0.00274	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—bone cancer	0.000844	0.00273	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—bone cancer	0.000837	0.00271	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—bone cancer	0.000834	0.0027	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—bone cancer	0.000816	0.00264	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—bone cancer	0.000812	0.00263	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—bone cancer	0.000803	0.0026	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—bone cancer	0.000797	0.00258	CcSEcCtD
Fluphenazine—Chlorpromazine—CYP3A4—bone cancer	0.000795	0.067	CrCbGaD
Fluphenazine—Body temperature increased—Methotrexate—bone cancer	0.000793	0.00257	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—bone cancer	0.000774	0.00251	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—bone cancer	0.000772	0.0025	CcSEcCtD
Fluphenazine—HRH1—tendon—bone cancer	0.000756	0.0103	CbGeAlD
Fluphenazine—Decreased appetite—Doxorubicin—bone cancer	0.000755	0.00244	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—bone cancer	0.000746	0.00241	CcSEcCtD
Fluphenazine—ADRA2A—tendon—bone cancer	0.000743	0.0101	CbGeAlD
Fluphenazine—Constipation—Doxorubicin—bone cancer	0.000743	0.0024	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—bone cancer	0.000742	0.0024	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—bone cancer	0.000739	0.00239	CcSEcCtD
Fluphenazine—CYP2E1—tendon—bone cancer	0.000727	0.00993	CbGeAlD
Fluphenazine—ADRA2A—spinal cord—bone cancer	0.000717	0.00979	CbGeAlD
Fluphenazine—Pruritus—Methotrexate—bone cancer	0.00071	0.0023	CcSEcCtD
Fluphenazine—CYP2E1—spinal cord—bone cancer	0.000701	0.00958	CbGeAlD
Fluphenazine—Hypersensitivity—Epirubicin—bone cancer	0.000692	0.00224	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—bone cancer	0.00069	0.00223	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—bone cancer	0.000687	0.00222	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—bone cancer	0.000664	0.00215	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—bone cancer	0.00064	0.00207	CcSEcCtD
Fluphenazine—HTR2A—tendon—bone cancer	0.000632	0.00863	CbGeAlD
Fluphenazine—Headache—Methotrexate—bone cancer	0.000628	0.00203	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—bone cancer	0.000614	0.00199	CcSEcCtD
Fluphenazine—HTR2A—spinal cord—bone cancer	0.000609	0.00832	CbGeAlD
Fluphenazine—Nausea—Methotrexate—bone cancer	0.000596	0.00193	CcSEcCtD
Fluphenazine—Headache—Epirubicin—bone cancer	0.000588	0.0019	CcSEcCtD
Fluphenazine—Nausea—Epirubicin—bone cancer	0.000558	0.0018	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—bone cancer	0.000544	0.00176	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—bone cancer	0.000516	0.00167	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—bone cancer	0.000401	0.00548	CbGeAlD
Fluphenazine—ABCB1—spinal cord—bone cancer	0.000399	0.00545	CbGeAlD
Fluphenazine—DRD2—Signaling Pathways—SMO—bone cancer	0.000153	0.000253	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ENO2—bone cancer	0.000153	0.000252	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ENO2—bone cancer	0.000153	0.000252	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—EGFR—bone cancer	0.000152	0.000251	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SMO—bone cancer	0.000151	0.000249	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SMO—bone cancer	0.00015	0.000248	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—GNA11—bone cancer	0.00015	0.000248	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KIT—bone cancer	0.000149	0.000247	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KIT—bone cancer	0.000149	0.000247	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—ATF1—bone cancer	0.000148	0.000245	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—ATF1—bone cancer	0.000148	0.000244	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—DHFR—bone cancer	0.000147	0.000243	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—EGFR—bone cancer	0.000147	0.000242	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—EGFR—bone cancer	0.000147	0.000242	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—DHFR—bone cancer	0.000147	0.000242	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL3—bone cancer	0.000145	0.000239	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL3—bone cancer	0.000144	0.000238	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFBR2—bone cancer	0.000144	0.000238	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFBR2—bone cancer	0.000142	0.000234	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—DHFR—bone cancer	0.000142	0.000234	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—DHFR—bone cancer	0.000142	0.000234	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—GNA11—bone cancer	0.00014	0.000231	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—GNA11—bone cancer	0.000138	0.000228	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—GNA11—bone cancer	0.000138	0.000227	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—GNA11—bone cancer	0.000138	0.000227	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000137	0.000226	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—GNA11—bone cancer	0.000137	0.000226	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—CYP3A4—bone cancer	0.000136	0.000225	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IGF1R—bone cancer	0.000135	0.000224	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IGF1R—bone cancer	0.000134	0.000221	CbGpPWpGaD
Fluphenazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000133	0.00022	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GNA11—bone cancer	0.000132	0.000219	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GNA11—bone cancer	0.000132	0.000219	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ATF1—bone cancer	0.00013	0.000215	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ATF1—bone cancer	0.000128	0.000212	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ATF1—bone cancer	0.000128	0.000211	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL3—bone cancer	0.000127	0.00021	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFBR2—bone cancer	0.000127	0.000209	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—MDM2—bone cancer	0.000127	0.000209	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000125	0.000207	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SMO—bone cancer	0.000125	0.000207	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL3—bone cancer	0.000125	0.000206	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—CYP3A4—bone cancer	0.000125	0.000206	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL3—bone cancer	0.000125	0.000206	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—CYP3A4—bone cancer	0.000124	0.000205	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFBR2—bone cancer	0.000124	0.000204	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFBR2—bone cancer	0.000123	0.000203	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFBR2—bone cancer	0.000123	0.000202	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFBR2—bone cancer	0.000123	0.000202	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—MDM2—bone cancer	0.000123	0.000202	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—MDM2—bone cancer	0.000123	0.000202	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—MDM2—bone cancer	0.000122	0.000201	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SMO—bone cancer	0.000121	0.0002	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SMO—bone cancer	0.000121	0.0002	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—CYP3A4—bone cancer	0.00012	0.000198	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—CYP3A4—bone cancer	0.00012	0.000198	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ENO2—bone cancer	0.00012	0.000198	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—MDM2—bone cancer	0.000118	0.000194	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—MDM2—bone cancer	0.000118	0.000194	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ATF1—bone cancer	0.000117	0.000193	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IGF1R—bone cancer	0.000116	0.000192	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—GSTP1—bone cancer	0.000116	0.000192	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IGF1R—bone cancer	0.000116	0.000191	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—GNA11—bone cancer	0.000115	0.000189	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KIT—bone cancer	0.000114	0.000188	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL3—bone cancer	0.000114	0.000188	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ENO2—bone cancer	0.000113	0.000186	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—DHFR—bone cancer	0.000111	0.000183	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—GNA11—bone cancer	0.000111	0.000183	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—GNA11—bone cancer	0.000111	0.000183	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—JUN—bone cancer	0.00011	0.000182	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFBR2—bone cancer	0.000109	0.000179	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—BRAF—bone cancer	0.000107	0.000177	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	0.000107	0.000177	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—GSTP1—bone cancer	0.000107	0.000176	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFBR2—bone cancer	0.000107	0.000176	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—JUN—bone cancer	0.000107	0.000176	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—JUN—bone cancer	0.000107	0.000176	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ATF1—bone cancer	0.000106	0.000176	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—GSTP1—bone cancer	0.000106	0.000175	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—DHFR—bone cancer	0.000105	0.000173	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—EGFR—bone cancer	0.000104	0.000172	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL3—bone cancer	0.000104	0.000171	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GNA11—bone cancer	0.000104	0.000171	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ATF1—bone cancer	0.000103	0.00017	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ATF1—bone cancer	0.000103	0.00017	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GSTP1—bone cancer	0.000103	0.00017	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GSTP1—bone cancer	0.000103	0.00017	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IGF1R—bone cancer	0.000102	0.000169	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IGF1R—bone cancer	0.000101	0.000166	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL3—bone cancer	0.0001	0.000166	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL3—bone cancer	0.0001	0.000166	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IGF1R—bone cancer	0.0001	0.000166	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KIT—bone cancer	9.82e-05	0.000162	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GNA11—bone cancer	9.78e-05	0.000161	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	9.73e-05	0.000161	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KIT—bone cancer	9.69e-05	0.00016	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ENO2—bone cancer	9.56e-05	0.000158	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CYP3A4—bone cancer	9.41e-05	0.000155	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KIT—bone cancer	9.37e-05	0.000155	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—BRAF—bone cancer	9.23e-05	0.000152	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	9.16e-05	0.000151	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—BRAF—bone cancer	9.11e-05	0.00015	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KIT—bone cancer	9.06e-05	0.00015	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KIT—bone cancer	9.06e-05	0.00015	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MDM2—bone cancer	8.99e-05	0.000148	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—EGFR—bone cancer	8.95e-05	0.000148	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFBR2—bone cancer	8.88e-05	0.000147	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CYP3A4—bone cancer	8.87e-05	0.000146	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—DHFR—bone cancer	8.86e-05	0.000146	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—bone cancer	8.85e-05	0.000146	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—EGFR—bone cancer	8.83e-05	0.000146	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—EGFR—bone cancer	8.66e-05	0.000143	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KIT—bone cancer	8.65e-05	0.000143	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFBR2—bone cancer	8.59e-05	0.000142	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFBR2—bone cancer	8.59e-05	0.000142	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KIT—bone cancer	8.45e-05	0.000139	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KIT—bone cancer	8.4e-05	0.000139	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—EGFR—bone cancer	8.38e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—EGFR—bone cancer	8.38e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KIT—bone cancer	8.37e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KIT—bone cancer	8.37e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF1R—bone cancer	8.35e-05	0.000138	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—EGFR—bone cancer	8.31e-05	0.000137	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GNA11—bone cancer	8.29e-05	0.000137	CbGpPWpGaD
Fluphenazine—CALM3—Disease—BRAF—bone cancer	8.13e-05	0.000134	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF1R—bone cancer	8.08e-05	0.000133	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF1R—bone cancer	8.08e-05	0.000133	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—bone cancer	8.08e-05	0.000133	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GSTP1—bone cancer	8.05e-05	0.000133	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—EGFR—bone cancer	8.04e-05	0.000133	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—EGFR—bone cancer	8.04e-05	0.000133	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—BRAF—bone cancer	7.94e-05	0.000131	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—BRAF—bone cancer	7.9e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM1—Disease—BRAF—bone cancer	7.87e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM2—Disease—BRAF—bone cancer	7.87e-05	0.00013	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—JUN—bone cancer	7.81e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—bone cancer	7.81e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—bone cancer	7.81e-05	0.000129	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MDM2—bone cancer	7.74e-05	0.000128	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—EGFR—bone cancer	7.7e-05	0.000127	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—EGFR—bone cancer	7.66e-05	0.000126	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MDM2—bone cancer	7.63e-05	0.000126	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—bone cancer	7.6e-05	0.000125	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GSTP1—bone cancer	7.58e-05	0.000125	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CYP3A4—bone cancer	7.51e-05	0.000124	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.47e-05	0.000123	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KIT—bone cancer	7.42e-05	0.000122	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MDM2—bone cancer	7.38e-05	0.000122	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KIT—bone cancer	7.3e-05	0.00012	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KIT—bone cancer	7.28e-05	0.00012	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MDM2—bone cancer	7.14e-05	0.000118	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MDM2—bone cancer	7.14e-05	0.000118	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—BRAF—bone cancer	6.97e-05	0.000115	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—BRAF—bone cancer	6.86e-05	0.000113	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—BRAF—bone cancer	6.85e-05	0.000113	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MDM2—bone cancer	6.81e-05	0.000112	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—EGFR—bone cancer	6.76e-05	0.000112	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—JUN—bone cancer	6.73e-05	0.000111	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MDM2—bone cancer	6.65e-05	0.00011	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—EGFR—bone cancer	6.65e-05	0.00011	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KIT—bone cancer	6.64e-05	0.00011	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—JUN—bone cancer	6.64e-05	0.00011	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—EGFR—bone cancer	6.64e-05	0.00011	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MDM2—bone cancer	6.62e-05	0.000109	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MDM2—bone cancer	6.59e-05	0.000109	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MDM2—bone cancer	6.59e-05	0.000109	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTGS2—bone cancer	6.57e-05	0.000108	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—bone cancer	6.54e-05	0.000108	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—bone cancer	6.46e-05	0.000107	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTP1—bone cancer	6.42e-05	0.000106	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—JUN—bone cancer	6.41e-05	0.000106	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTGS2—bone cancer	6.35e-05	0.000105	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTGS2—bone cancer	6.35e-05	0.000105	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—BRAF—bone cancer	6.24e-05	0.000103	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—JUN—bone cancer	6.21e-05	0.000102	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—JUN—bone cancer	6.21e-05	0.000102	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—EGFR—bone cancer	6.14e-05	0.000101	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KIT—bone cancer	6.06e-05	0.0001	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	6.05e-05	9.98e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—bone cancer	6.03e-05	9.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KIT—bone cancer	5.86e-05	9.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KIT—bone cancer	5.86e-05	9.67e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MDM2—bone cancer	5.84e-05	9.64e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—JUN—bone cancer	5.78e-05	9.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—JUN—bone cancer	5.75e-05	9.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MDM2—bone cancer	5.75e-05	9.49e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MDM2—bone cancer	5.74e-05	9.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—BRAF—bone cancer	5.69e-05	9.4e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—bone cancer	5.63e-05	9.29e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—bone cancer	5.6e-05	9.24e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—bone cancer	5.54e-05	9.14e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EGFR—bone cancer	5.52e-05	9.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—BRAF—bone cancer	5.51e-05	9.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—BRAF—bone cancer	5.51e-05	9.09e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—bone cancer	5.5e-05	9.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EGFR—bone cancer	5.34e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EGFR—bone cancer	5.34e-05	8.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—bone cancer	5.32e-05	8.78e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—bone cancer	5.32e-05	8.78e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EGFR—bone cancer	5.29e-05	8.73e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MDM2—bone cancer	5.23e-05	8.63e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EGFR—bone cancer	5.22e-05	8.61e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—bone cancer	5.16e-05	8.51e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—JUN—bone cancer	5.08e-05	8.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—bone cancer	5.04e-05	8.32e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—JUN—bone cancer	5e-05	8.25e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—JUN—bone cancer	4.99e-05	8.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—bone cancer	4.94e-05	8.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—bone cancer	4.88e-05	8.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—bone cancer	4.88e-05	8.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—bone cancer	4.86e-05	8.02e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—bone cancer	4.85e-05	8e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MDM2—bone cancer	4.77e-05	7.87e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—bone cancer	4.66e-05	7.68e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—bone cancer	4.62e-05	7.62e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—bone cancer	4.62e-05	7.62e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—bone cancer	4.55e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—bone cancer	4.55e-05	7.5e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—bone cancer	4.52e-05	7.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—bone cancer	4.5e-05	7.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—bone cancer	4.5e-05	7.43e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—bone cancer	4.44e-05	7.33e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—bone cancer	4.42e-05	7.3e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—bone cancer	4.38e-05	7.23e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—bone cancer	4.17e-05	6.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—bone cancer	4.15e-05	6.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—bone cancer	4.04e-05	6.66e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—bone cancer	4.01e-05	6.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—bone cancer	4.01e-05	6.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—bone cancer	3.99e-05	6.59e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—bone cancer	3.93e-05	6.48e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—bone cancer	3.93e-05	6.48e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—bone cancer	3.92e-05	6.47e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—bone cancer	3.9e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—bone cancer	3.9e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—bone cancer	3.82e-05	6.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—bone cancer	3.8e-05	6.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—bone cancer	3.57e-05	5.9e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—bone cancer	3.35e-05	5.53e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—bone cancer	3.33e-05	5.49e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—bone cancer	3.3e-05	5.44e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—bone cancer	3.29e-05	5.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—bone cancer	3.26e-05	5.38e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—bone cancer	3.15e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—bone cancer	3.15e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—bone cancer	3e-05	4.95e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—bone cancer	2.74e-05	4.52e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—bone cancer	2.65e-05	4.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—bone cancer	2.65e-05	4.37e-05	CbGpPWpGaD
